Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Innoviva Analyst Ratings and Price Targets | NASDAQ:INVA | Benzinga
Innoviva Inc has a consensus price target of $25.13 based on the ratings of 5 analysts. The high is $55 issued by Scotiabank on March 7, 2025. The low is $10 issued by Morgan Stanley on March 3, 2023. The 3 most-recent analyst ratings were released by Scotiabank, EF Hutton, and EF Hutton on March 7, 2025, May 10, 2023, and April 20, 2023, respectively. With an average price target of $33.33 between Scotiabank, EF Hutton, and EF Hutton, there's an implied 84.06% upside for Innoviva Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Scotiabank
EF Hutton
Goldman Sachs
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Innoviva
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/07/2025 | Buy Now | 203.7% | Scotiabank | Louise Chen57% | → $55 | Initiates | → Sector Outperform | Get Alert |
| 08/01/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen57% | — | Reiterates | → Overweight | Get Alert |
| 07/30/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen57% | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen57% | — | Reiterates | → Overweight | Get Alert |
| 06/18/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen57% | — | Initiates | → Overweight | Get Alert |
| 05/10/2023 | Buy Now | 24.24% | EF Hutton | Constantine Davides38% | → $22.5 | Reiterates | → Buy | Get Alert |
| 04/20/2023 | Buy Now | 24.24% | EF Hutton | Constantine Davides38% | → $22.5 | Reiterates | → Buy | Get Alert |
| 03/03/2023 | Buy Now | -28.22% | Goldman Sachs | Chris Shibutani54% | $15 → $13 | Maintains | Neutral | Get Alert |
| 03/03/2023 | Buy Now | -44.78% | Morgan Stanley | Matthew Harrison60% | $13 → $10 | Maintains | Underweight | Get Alert |
| 03/03/2023 | Buy Now | 24.24% | EF Hutton | Constantine Davides38% | → $22.5 | Reiterates | → Buy | Get Alert |
| 01/24/2023 | Buy Now | -28.22% | Morgan Stanley | Matthew Harrison60% | $14 → $13 | Maintains | Underweight | Get Alert |
| 10/13/2022 | Buy Now | -22.69% | Morgan Stanley | Matthew Harrison60% | $13 → $14 | Maintains | Underweight | Get Alert |
| 08/08/2022 | Buy Now | -28.22% | Morgan Stanley | Matthew Harrison60% | $12 → $13 | Maintains | Underweight | Get Alert |
| 07/20/2022 | Buy Now | -11.65% | Goldman Sachs | Chris Shibutani54% | → $16 | Initiates | → Neutral | Get Alert |
| 07/15/2022 | Buy Now | -33.74% | Morgan Stanley | Matthew Harrison60% | $13 → $12 | Maintains | Underweight | Get Alert |
| 04/12/2022 | Buy Now | -28.22% | Morgan Stanley | Matthew Harrison60% | $12 → $13 | Maintains | Underweight | Get Alert |
FAQ
What is the target price for Innoviva (INVA) stock?
The latest price target for Innoviva (NASDAQ:INVA) was reported by Scotiabank on March 7, 2025. The analyst firm set a price target for $55.00 expecting INVA to rise to within 12 months (a possible 203.70% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Innoviva (INVA)?
The latest analyst rating for Innoviva (NASDAQ:INVA) was provided by Scotiabank, and Innoviva initiated their sector outperform rating.
When was the last upgrade for Innoviva (INVA)?
There is no last upgrade for Innoviva
When was the last downgrade for Innoviva (INVA)?
There is no last downgrade for Innoviva.
When is the next analyst rating going to be posted or updated for Innoviva (INVA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Innoviva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Innoviva was filed on March 7, 2025 so you should expect the next rating to be made available sometime around March 7, 2026.
Is the Analyst Rating Innoviva (INVA) correct?
While ratings are subjective and will change, the latest Innoviva (INVA) rating was a initiated with a price target of $0.00 to $55.00. The current price Innoviva (INVA) is trading at is $18.11, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.